Tubal patency after clinical treatment of unruptured ectopic pregnancy

Tubal patency after clinical treatment of unruptured ectopic pregnancy

Autor Elito, J. Google Scholar
Han, K. K. Google Scholar
Camano, L. Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Objective: To evaluate tubal patency using hysterosalpingography after clinical treatment of tubal pregnancy. Method: of 80 patients who underwent hysterosalpingography after clinical treatment of tubal pregnancy from April 1994 to February 2002, 30 were treated with a single 50 mg/m(2) dose of methotrexate intramuscularly (n=30) and 50 were followed up expectantly. Results: Patency of the ipsilateral tube was 84% after methotrexate treatment and 78% after expectant management. in addition, contralateral tubal. patency was 97% after methotrexate treatment and 92% after expectant management. There were no statistically significant differences between the groups. Conclusion: Findings from this study suggest similar tubal patency rates after methotrexate treatment and expectant management. (c) 2005 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Palavra-chave ectopic pregnancy
methotrexate
expectant management
chorionic gonadotropic hormone
hysterosalpingography
Idioma Inglês
Data de publicação 2005-03-01
Publicado em International Journal of Gynecology & Obstetrics. Clare: Elsevier Sci Ireland Ltd, v. 88, n. 3, p. 309-313, 2005.
ISSN 0020-7292 (Sherpa/Romeo, fator de impacto)
Publicador Elsevier B.V.
Extensão 309-313
Fonte http://dx.doi.org/10.1016/j.ijgo.2004.12.018
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000227833700013
Endereço permanente http://repositorio.unifesp.br/handle/11600/28177

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta